EurekAlert! -
25 Mar 2020 06:00
(University of Texas M. D. Anderson Cancer Center) MD Anderson researchers find that treating T cells with panobinostat and IL-21 re-programs them to a powerful central memory T cell type that persists longer.
Share this Article